Glycemic Response

2

Review clinical trials related to Glycemic Response. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Impact of Reducose® on Glycemic Response and Menopausal Symptoms in Perimenopausal Women (CALM-R)

The purpose of this double-blind, randomized, placebo-controlled trial is to. evaluate daily Reducose® (mulberry leaf extract) supplementation taken with the two largest meals for 12 weeks on improving glycemic response and perimenopausal symptoms in women aged 40-60 years. Glycemic response is measured using Dexcom Stelo continuous glucose monitors during standardized test meals, and menopausal symptoms and sleep/quality-of-life outcomes are assessed using validated surveys administered through the Chloe app in a decentralized U.S. study.

Participants needed: 120
Trial details
Age: 40-60Biological sex: FemaleType: InterventionalSponsor: Phynova Group LtdUpdated: Jan 12, 2026Locations: 1
Eligibility criteria

Participants assigned female at birth (aged 40-60 years) will be recruited for t... [+14]

Participants assigned male at birth. [+25]

Status: Recruiting

Interaction Between White Potato Consumption and Meal Timing on Glycemic Response and Appetite in Adults

The purpose of this study is to evaluate the interaction between white potato consumption and meal timing on glycemic response, subjective appetite, and energy intake in adults. The investigators hypothesize that white potatoes will modulate glycemic response, enhance satiety, and mitigate subsequent meal consumption and overall food intake when compared with meals containing low glycemic carbohydrates. Furthermore, they anticipate that the timing of white potato consumption will yield differential effects, with breakfast consumption exerting a more pronounced impact on satiety and subsequent food intake reduction compared to dinner consumption.

Participants needed: 30
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Toronto Metropolitan UniversityUpdated: Nov 17, 2025Locations: 1
Eligibility criteria

18 - 65 years [+1]

have a previous diagnosis of diabetes and gastrointestinal, liver or kidney dise... [+5]